Available under the brand names Wegovy and Ozempic, Semaglutide is administered once weekly and has gained popularity for its effectiveness in helping patients achieve sustained weight loss
Most manufacturers recommend maintaining at least 2 inches (approximately 5 centimeters) away from the belly button itself to ensure adequate subcutaneous tissue depth and avoid potential complications
The approved dosing for both indications involves subcutaneous injection once weekly, with gradual dose escalation from 2.5 mg to maintenance doses of 5 mg, 10 mg, or 15 mg based on individual response and tolerability
New breast lumps or changes in breast tissue require evaluation
Sahiner M, Yilmaz AS, Ayyala RS, Sahiner N
This works for motivated patients tolerating mild transient side effects but risks premature discontinuation if effects become overwhelming